PBCers Organization
PBCers Organization is the largest primary biliary cholangitis (PBC) online support group worldwide, consisting of patients, families, and caregivers. The organization hopes that through education and discussions, “no one will feel alone with PBC.”
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Resources & Support
Patient Worthy Posts on Primary Biliary Cholangitis
A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target
The company Genkyotex has announced that they have finished enrolling participants for a Phase 2 clinical trial of the investigational drug GKT831 in patients who
This New Treatment Could Help Patients With Primary Biliary Cholangitis
According to an article from Financial Buzz, the pharmaceutical company CymaBay Therapeutics has announced that the first of its patients have begun to enroll in
Making Strides Towards New Treatment Options for Nonalcoholic Steatohepatitis
Nonalcoholic steatohepatitis (NASH), is condition most commonly caused by obesity or type 2 diabetes. It can result in fibrosis, complications in the lung and cardiac
September is Primary Biliary Cholangitis (PBC) Awareness Month!
September is Primary Biliary Cholangitis Awareness Month! What is PBC? Primary biliary cholangitis (PBC) is a chronic disease of the liver characterized by a slow, progressive
Experimental Treatment for Primary Biliary Cholangitis Earns Orphan Drug Status in the US and EU
According to a story from Markets Insider, the biopharmaceutical company GENFIT recently announced that both the European Medicines Agency (EMA) and the US Food and
Mouse Model Continues to Show Efficacy of GKT831 for Treating Cholestatic Fibrosis in Primary Biliary Cholangitis
Preclinical data supporting the efficacy of GKT831 as a potential therapy for cholestatic fibrosis has just been published in the Journal of Hepatology. GKT831 GKT831 is
